Pancreatic Cell News

Pancreatic Cell News is an online resource providing updates on the latest pancreatitis, diabetes, and pancreatic cancer research.

Subscribe|Follow Us On    

Pancreatic δ Cells Are Resistant to Auto- and Paracrine Inhibition in Human Type-2 Diabetes

[Proceedings of The National Academy of Sciences of The United States of America] Researchers compared the function of isolated pancreatic δ cells of cadaveric nondiabetic and T2D donors by single cell total internal reflection microscopy, electrophysiology, and secretion measurements.

Cysteine Promotes Islet α-Cell Glucagon Secretion by Limiting Oxidative Inhibition of Voltage-Gated Sodium Channels

[Redox Biology] Scientists identified cysteine as a key regulator of islet glucagon secretion through redox control of α-cell electrical excitability.

Imeglimin at Clinical Doses Promotes Glucose-Stimulated Insulin Secretion and Mitochondrial Supercomplex Formation

[Endocrinology] Investigators examined the effects of imeglimin, a novel antidiabetic agent, in normal glucose-tolerant C57BL/6 mice and isolated mouse islets using concentrations corresponding to clinically achieved plasma levels.

The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma

[Cancer Immunology Research] The authors reported that the RNA-binding protein human antigen R (HuR) is enriched in human PDAC and negatively correlates with T cell infiltration.

Saturation Mutagenesis Library Screening Identifies On-Target Secondary Resistance Mutations in KRASG12D-Selective Inhibitors

[Cancer Letters] Researchers conducted a saturation mutagenesis library screening of the full-length Kirsten rat sarcoma virus gene (KRAS)G12D protein in a pancreatic cancer cell line carrying KRASG12D mutation to explore the drug resistance characteristics of KRASG12D-selective inhibitors.

Dual mTORC1/2 and Scd1 Inhibition Uncovers a Therapeutic Vulnerability in Pancreatic Cancer

[Diabetes] Using genetically engineered mouse models and matched organoids, scientists dissected complex-specific adaptive programs elicited by selective inactivation of mechanistic target of rapamycin (mTOR)C1 or mTORC2. Hyperactivation of mTORC1 and mTORC2 is common in PDAC.

Selective AUTAC-Mediated ATP7B Degradation Unlocks Cuproptosis Vulnerability in Pancreatic Ductal Adenocarcinoma

[Oncogene] Investigators developed an copper-transporting ATPase 2 (ATP7B)-targeting autophagy-targeting chimera (AUTAC), the first autophagy-tethering compound specifically designed to target ATP7B.

Integrated Bulk and Single-Cell Transcriptomic Analysis Reveals Inflammatory Metabolic Programs in Pancreatic Ductal Adenocarcinoma

[Translational Oncology] Researchers integrated bulk and single-cell transcriptomic datasets to characterize inflammation-associated metabolic programs in PDAC.

Multifaceted Role of Genetic and Epigenetic Architecture of Glucose Homeostasis and Diabetes

[npj Metabolic Health and Disease] The authors synthesize evidence from over 600 GWAS loci and the primary literature published between 2008 and 2026 to explain insulin secretion, insulin signaling, and diabetes susceptibility, converting GWAS associations into mechanistic insight and genotype-guided precision therapies.

vTv Therapeutics Announces First Participant Randomized in Phase IIa Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL)...

[vTv Therapeutics, Inc.] vTv Therapeutics, Inc. announced that the first participant has been randomized in its Phase IIa Hybrid CATT1 pilot study evaluating cadisegliatin in individuals with T1D who use HCL insulin delivery systems.

Sequential Dual Nanoparticle Approach for Extracellular Matrix Remodeling and Targeted Chemotherapy through Liposome-Exosome Hybridization in Pancreatic Cancer

[ACS Applied Materials & Interfaces] Researchers reported a sequential dual-nanoparticle approach that integrates ECM remodeling with tumor-targeted chemotherapy to overcome the insufficient tumor targeting and poor intratumoral penetration of liposomal doxorubicin.

Glucose Controls Metallothionein 1 Gene Expression in Pancreatic Islets via a Mechanism Involving Cellular Metabolism, Granular Zinc, and the Zinc Transporter ZnT8 in Rat and...

[Diabetologia] Researchers examined whether physiological changes in blood glucose levels in vivo control islet metallothionein 1 gene expression similarly to ex vivo observations, and identify the mechanisms involved.

Pancreatic Cell News highlights recent top articles in the field of pancreatic cell research. These articles have been carefully selected from high-impact, peer-reviewed academic journals by our experienced editorial team. We cover topics including pancreatic cell culture, pancreatitis, diabetes, and pancreatic cancer. We also feature the latest industry and policy news alongside job postings and upcoming events to keep scientists current while saving them valuable time.

spot_img